aibioPACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) news
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PACB, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest PACIFIC BIOSCIENCES OF CALIFORNIA, INC. news
We have not published a story on PACIFIC BIOSCIENCES OF CALIFORNIA, INC. yet. When there is news, it will appear here.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $97.3 million | $134.9 million |
| Net income (loss) | -$546.4 million | -$309.9 million |
| Cash from operations | -$111.2 million | -$206.1 million |
| Cash and equivalents | $63.7 million | $55.4 million |
| Short-term investments | $215.8 million | $334.6 million |
Questions about PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
What is the ticker symbol of PACIFIC BIOSCIENCES OF CALIFORNIA, INC.?
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. trades under the ticker PACB on NASDAQ.
Where is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. listed?
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is listed on NASDAQ.
Which country or territory is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. listed under?
Our directory records PACIFIC BIOSCIENCES OF CALIFORNIA, INC. under United States.
Does aibio.space cover PACIFIC BIOSCIENCES OF CALIFORNIA, INC.?
aibio.space lists PACIFIC BIOSCIENCES OF CALIFORNIA, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
Is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. profitable?
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported a net loss of $546.4 million for the fiscal year ended Dec 31, 2025, and used $111.2 million of cash in operations, per its annual report to the SEC.
How much does PACIFIC BIOSCIENCES OF CALIFORNIA, INC. spend on research and development?
$97.3 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does PACIFIC BIOSCIENCES OF CALIFORNIA, INC. have?
$236.9 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Distress
Reported a restructuring, a workforce reduction or a review of strategic alternatives. SEC Form 8-K (Items 2.02,2.05,5.02,7.01,9.01). Source
Stock chart
Listing details
- Company
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker
- PACB
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction